News
Aberforth Geared Value & Income Trust plcAudited Annual Results for the period from Incorporation on 29 March 2024 to 30 June 2025 ...
Received U.S. FDA approval for EMPAVELI® (pegcetacoplan) for treatment of patients 12 years and older with C3G and primary IC-MPGNAnnounced capped royalty purchase agreement with Sobi under which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback